By themselves, insulin-based treatments do not adequately control glycemic variations (or excursions) in type 1 diabetes in a consistent fashion.…
In this study, researchers added liraglutide, often used to treat type 2 diabetes, to insulin treatment to see if it would provide better control for those with type 1 diabetes. Doing so significantly reduced excursions of blood glucose levels, allowed for lower doses of insulin, resulted in weight loss and also lowered A1C levels. When liraglutide was removed from treatment, there was a prompt reversal of these effects.
ADA Scientific Sessions (411-PP) June 26, 2011
Editors Note: This is NOT an FDA approved use of the drug.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.